摘要
G蛋白耦联受体30(GPR30)是一种新鉴定的雌激素功能性膜受体,介导雌激素的快速非基因组效应,从而广泛参与机体的病理生理调控,尤其在激素相关性恶性肿瘤中的的发生发展过程中起重要作用。
G protein-coupled receptor 30 ( GPR30), a sort of novel functional estrogen transmembrane receptor, extensively participate in the pathological and physiological regulation by mediating the rapid nongenomic effects of the estrogen, which plays an important role in the occurrence and development of the hormone-related malignant neoplasms.
出处
《国际肿瘤学杂志》
CAS
2012年第3期166-169,共4页
Journal of International Oncology
基金
基金项目:国家自然科学基金资助项目(81001154)